Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market: Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen… read more
Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides: Jennewein Biotechnologie GmbH today announces the publication of the latest… read more
Supply of Key Ingredient in advanced infant formula by Jennewein is secured: Jennewein Biotechnologie GmbH, a worldwide leading manufacturer of human milk… read more
Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-Mix: Jennewein Biotechnology announces another milestone in the Worldwide approval of… read more
Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2’-fucosyllactose fermentation strain.: Nov. 25th. 2019, Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer… read more
